| [1] |
HE Dandan, LI Jian, WANG Chunjuan, LI Shuya.
Challenges and Breakthroughs in Basic and Clinical Research of Brain Cytoprotective Agents for Acute Ischemic Stroke in China
[J]. Chinese Journal of Stroke, 2026, 21(5): 517-524.
|
| [2] |
CHENG Xiyue, ZHAO Jingyan, WANG Chunjuan.
Research Progress of Edaravone Dexborneol in Brain Cytoprotection for Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2026, 21(5): 526-532.
|
| [3] |
YANG Qianqian, ZHANG Meiyang, LU Yao, ZHOU Dongyang, WANG Zhengyilei, Shan Shuyi, LIU Chenhui, WANG Yilong, GUAN Ling.
Research Progress on the Anti-Neuroinflammatory Effects and Brain Cytoprotection of Minocycline in Acute Ischemic Stroke: From Mechanisms to Clinical Evidence
[J]. Chinese Journal of Stroke, 2026, 21(5): 533-542.
|
| [4] |
HE Dandan, LI Shuya.
Research Progress of PSD-95-Targeted Brain Cytoprotective Agents in Acute Ischemic Stroke Based on STAIR Principles
[J]. Chinese Journal of Stroke, 2026, 21(5): 543-552.
|
| [5] |
CHANG-CAO Wenjing, XU Shuhong, LI Jian, LI Shuya.
Research Progress on the Relationship between the Apolipoprotein E Gene and Brain Injury after Ischemic Stroke
[J]. Chinese Journal of Stroke, 2026, 21(5): 570-576.
|
| [6] |
LI Wenyi, JIANG Jiwei, REN Qiwei, WANG Linlin, ZHAO Min, XU Jun.
A Study on the Correlation between Apolipoprotein E Gene Polymorphism and Cognitive Function Changes after Stroke
[J]. Chinese Journal of Stroke, 2026, 21(5): 577-584.
|
| [7] |
LIU Yuanhao, WU Lei, YANG Huan, ZHU Jiaying, LI Yazhe.
Efficacy and Safety of Different Thrombectomy Devices in the Treatment of Acute Ischemic Stroke: A Retrospective Comparative Study
[J]. Chinese Journal of Stroke, 2026, 21(4): 463-470.
|
| [8] |
OU Ru, LIU Yimin, XU Zhijian, HUANG Wenchun.
Dynamic Effects of Lacunes of Presumed Vascular Origin on Health Status in Patients with Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2026, 21(3): 312-319.
|
| [9] |
LI Li, DUAN Zhenhui, GAO Aihua, PAN Songbin.
Correlation Analysis and Prediction Model Construction of Frailty Index, Nutritional Risk, and Nosocomial Infection Risk after Intravenous Thrombolysis in Elderly Patients with Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2026, 21(3): 331-337.
|
| [10] |
National Center for Healthcare Quality Management in Neurological Diseases, Medical Quality Management and Promotion Branch of the Chinese Stroke Association, Interventional Neuroradiology Branch of the Chinese Stroke Association.
Expert Recommendations on Evaluation and Improvement of Healthcare Quality for Reperfusion Therapy in Acute Ischemic Stroke (2026)
[J]. Chinese Journal of Stroke, 2026, 21(3): 338-352.
|
| [11] |
ZHANG Zili, ZHAO Ying, MENG Heng, XU Anding.
Research Progress on Predicting Futile Recanalization following Endovascular Treatment in Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2026, 21(3): 378-386.
|
| [12] |
YAO Li, WU Chuanjie.
Interpretation of the Key Updates on Endovascular Therapy in the 2026 Guideline for the Early Management of Patients with Acute Ischemic Stroke: A Guideline from the American Heart Association/American Stroke Association
[J]. Chinese Journal of Stroke, 2026, 21(2): 234-239.
|
| [13] |
XIONG Yunyun, LU Zhengzhao, MA Ying, SHAN Dawei, WU Na, HAO Manjun, MA Yujie, WU Shuangzhe, LI Zhixin, SHEN Kejia, TANG Yizhe, WANG Yongjun.
Highlights in Stroke in 2025
[J]. Chinese Journal of Stroke, 2026, 21(1): 1-23.
|
| [14] |
HE Dandan, XU Shuhong, LI Shuya.
Clinical Research and Prospects of Novel Intravenous Thrombolytic Agents for Acute Ischemic Stroke within the Standard Time Window
[J]. Chinese Journal of Stroke, 2026, 21(1): 24-29.
|
| [15] |
HUANG Xuyang, LI Runhui.
Comparison of Short-Term Neurological Function Recovery between Tenecteplase and Alteplase in Patients with Acute Ischemic Stroke: A Linear Mixed-Effects Model Analysis
[J]. Chinese Journal of Stroke, 2026, 21(1): 31-37.
|